全自动CT脂肪评估:L1与L3椎体水平对机会性预测死亡率的比较
本研究在9066例无症状成人低剂量腹部CT中,用AI工具自动测量L1与L3水平的内脏脂肪面积(VAT)、皮下脂肪面积(SAT)及二者比值(VSR),比较其预测死亡率的效能。中位随访8.8年,5.9%死亡;L1与L3的VAT和SAT预测10年死亡AUC无显著差异,但L3的VSR显著更优;L1的VAT和VSR仍可预测生存,有望将机会性筛查扩展至胸部CT。
要点
- L1水平VAT和VSR可预测死亡率,但整体略逊于标准L3水平。
- L3水平VSR预测死亡率显著优于L1水平VSR。
- 利用L1脂肪指标可将机会性筛查扩展至胸部CT。
核心结论
- L1水平自动CT测量的VAT和VSR可预测生存,但整体脂肪指标略逊于标准L3水平。
- L3水平VSR预测死亡率显著优于L1水平VSR。
- 利用L1水平预测性脂肪指标可将机会性筛查扩展至胸部CT。
研究设计与样本
- 回顾性研究,纳入9066例无症状成人(平均年龄57.1±7.8岁;男4020例,女5046例),因结直肠癌筛查接受平扫低剂量腹部CT。
- 使用先前验证的人工智能工具评估L1和L3水平的横断面内脏脂肪面积(VAT)、皮下脂肪面积(SAT)及其比值(VSR)。
- 采用ROC曲线下面积(AUC)和风险比(HR)比较CT后生存预测。
- 中位临床随访8.8年(四分位距5.2-11.6年),期间5.9%(532/9066)死亡。
诊断标准与关键数值
- L1与L3的VAT和SAT预测10年死亡AUC无显著差异(p>0.05)。
- L3的VSR预测10年死亡AUC显著优于L1(p<0.001)。
- L1与L3的VAT预测死亡率最差与最佳四分位HR分别为2.12(95%CI 1.65-2.72)和2.22(95%CI 1.74-2.83)。
- L1与L3的SAT预测死亡率最差与最佳四分位HR分别为1.20(95%CI 0.95-1.52)和1.16(95%CI 0.92-1.46)。
- L1与L3的VSR预测死亡率最差与最佳四分位HR分别为2.26(95%CI 1.7-2.93)和3.05(95%CI 2.32-4.01);女性中VSR对应HR分别为2.58(95%CI 1.80-3.69)和4.49(95%CI 2.98-6.78)。
临床应用与阅片要点
- 在胸部CT(可评估L1水平)中可机会性测量VAT和VSR以辅助风险分层。
- 腹部CT仍建议以L3水平VSR作为优先脂肪指标,因其预测死亡率更优。
- 注意L1与L3水平测量值不可直接互换,报告时应注明测量层面。
局限性
- 回顾性单中心设计可能限制外推性。
- 仅纳入接受结直肠癌筛查的无症状成人,结论未必适用于其他人群。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: The purpose of this study is to compare fully automated CT-based measures of adipose tissue at the L1 level versus the standard L3 level for predicting mortality, which would allow for use at both chest (L1) and abdominal (L3) CT.
METHODS: This retrospective study of 9066 asymptomatic adults (mean age, 57.1 ± 7.8 [SD] years; 4020 men, 5046 women) undergoing unenhanced low-dose abdominal CT for colorectal cancer screening. A previously validated artificial intelligence (AI) tool was used to assess cross-sectional visceral and subcutaneous adipose tissue areas (SAT and VAT), as well as their ratio (VSR) at the L1 and L3 levels. Post-CT survival prediction was compared using area under the ROC curve (ROC AUC) and hazard ratios (HRs).
RESULTS: Median clinical follow-up interval after CT was 8.8 years (interquartile range, 5.2-11.6 years), during which 5.9% died (532/9066). No significant difference (p > 0.05) for mortality was observed between L1 and L3 VAT and SAT at 10-year ROC AUC. However, L3 measures were significantly better for VSR at 10-year AUC (p < 0.001). HRs comparing worst-to-best quartiles for mortality at L1 vs. L3 were 2.12 (95% CI, 1.65-2.72) and 2.22 (1.74-2.83) for VAT; 1.20 (0.95-1.52) and 1.16 (0.92-1.46) for SAT; and 2.26 (1.7-2.93) and 3.05 (2.32-4.01) for VSR. In women, the corresponding HRs for VSR were 2.58 (1.80-3.69) (L1) and 4.49 (2.98-6.78) (L3).
CONCLUSION: Automated CT-based measures of visceral fat (VAT and VSR) at L1 are predictive of survival, although overall measures of adiposity at L1 level are somewhat inferior to the standard L3-level measures. Utilizing predictive L1-level fat measures could expand opportunistic screening to chest CT imaging.
引用
- Liu, Garrett, Lee, et al. Fully automated CT-based adiposity assessment: comparison of the L1 and L3 vertebral levels for opportunistic prediction. Abdom Radiol (NY). 2022. PMID: 36369528. doi:10.1007/s00261-022-03728-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。